The Warm Handoff: Depression and Mood

In previous posts, I described the warm handoff as one of the defining features of the Primary Care Behavioral Health (PCBH) model—a same-day, in-person introduction that transforms a referral slip into a genuine clinical encounter. Now it is time to put that mechanism to work. Over the next several posts, I will walk through, at a very high level, what warm handoffs look like for specific presenting concerns, beginning with the one that occupies more of a behavioral health consultant’s schedule than any other: depression. A caveat belongs at the front: depression is not the BHC’s exclusive domain, nor should it be. The PCBH model is built around population-level care, and a program that quietly funnels the BHC into something resembling a mood disorder specialty clinic has drifted from its purpose. Future posts in this series will address warm handoffs for medical conditions—diabetes, hypertension, chronic pain—precisely to make that point concrete. But to discuss anything honestly, we have to start where the referrals actually come from.

Depression rarely announces itself with the clarity we might hope for. Herman Melville understood this more than a century before the PHQ-9 existed. In Bartleby, the Scrivener his pale, motionless copyist does not declare himself unwell—he simply stops. He stops copying, stops eating, stops leaving the office, retreating into a kind of gray refusal that his employer cannot name and cannot reach. “I would prefer not to,” Bartleby says, again and again, to every offered task and every extended hand. The story is usually read as an allegory of alienated labor, but it is also one of the most clinically precise portraits of major depression in the American canon: the anhedonia, the psychomotor retardation, the social withdrawal, the passivity that reads to observers as stubbornness or indifference. The Wall Street lawyer who employs Bartleby is at a loss because he has no framework for what he is seeing. Primary care, at its best, is the place where that framework finally exists—and where someone is actually present to use it.

The Scope of the Problem

Depression is among the most burdensome conditions managed in primary care. Estimates of its prevalence in primary care settings vary depending on the population studied and the diagnostic method used, but point prevalence figures in the range of 5–13% are commonly reported in the literature , with substantially higher rates in clinics serving low-income or medically complex populations. Globally, depression and anxiety together account for a significant share of the years lived with disability attributed to any cause .

These numbers acquire particular weight in the primary care context because primary care is where most people with depression, to borrow Sherlock Holmes’s language, present the facts without naming the culprit. Patients do not typically walk in and say they are depressed. They describe fatigue, insomnia, headaches, and vague abdominal complaints—somatic presentations that can mask an underlying mood disorder with enough fidelity to mislead even experienced clinicians. Gates and colleagues found that 13–25% of primary care patients who present with physical complaints have underlying depression or anxiety , which is a sobering statistic for any clinician who believes somatic complaints can be sorted neatly into physical and emotional bins.

The problem is compounded by the well-documented treatment gap. Most people with depression in the United States never receive any treatment for it, and those who do often face delays of years between symptom onset and a first clinical conversation that addresses it directly . Specialty mental health care—which provides excellent, often life-changing care to those who can access it—cannot close that gap: the capacity simply does not exist. Primary care, by virtue of its reach into nearly every demographic and geographic corner of the country, is the only plausible site of meaningful population-level intervention. That is not a rhetorical flourish; it is the reason PCBH exists.

Depression Is Not the BHC’s Alone

Before describing what the warm handoff for depression looks like, it is worth establishing what it is not meant to accomplish. The warm handoff is not a referral—a transfer of ownership—with the referring provider stepping back once the introduction is made. In PCBH, the PCP remains the patient’s primary clinician. The BHC’s role is to assist in the assessment, to intervene briefly, and to support what the PCP is already doing rather than to replace it. The work is fundamentally collaborative. (GATHER: Team-based; 4 Cs: Coordination—the BHC extends and supports the PCP rather than replacing the care relationship )

This matters especially in depression care. Antidepressant prescribing, medication titration, monitoring for side effects, and tracking treatment response over time all continue to sit with the PCP. What the BHC adds is behavioral: psychoeducation about the connection between activity and mood, a functional assessment of what depression is costing the patient in daily terms, psychoeducation about side effects and time to benefits, and an initial plan that the patient can begin acting on before they leave the clinic. Follow-up will include monitoring adherence, symptom change, side effects, and functional changes. Robinson and Reiter capture this orientation with the phrase “skills before pills”—the idea that a brief behavioral intervention should typically precede, or at minimum accompany, a psychotropic prescription, and that the BHC is the team member best positioned to deliver it. Williams has argued that integrated behavioral health should function more like primary care itself—a universal, prevention-oriented point of contact rather than a downstream service—and that aspiration is undermined whenever the BHC becomes the designated depression clinician and the PCP becomes the designated prescription writer. (GATHER: Educator—the BHC delivers brief behavioral intervention and psychoeducation as a core contribution to the shared care plan.)

None of this diminishes the significance of what the BHC contributes. It clarifies it. The BHC brings clinical skills that most PCPs do not have time to deploy: structured behavioral assessment, behaviorally-grounded evidence-based interventions, measurement-based tracking of treatment response, and the ability to identify when a case exceeds what primary care can reasonably hold. That is a substantial contribution. It is simply not the same as owning the problem.

Screening in Primary Care: The PHQ-9

Most warm handoffs for depression in a PCBH clinic begin not with a physician’s hunch but with a number. The Patient Health Questionnaire-9 (PHQ-9) is a nine-item self-report instrument derived from the diagnostic criteria for major depressive disorder in the Diagnostic and Statistical Manual of Mental Disorders . It is brief enough to complete in a waiting room, sensitive enough to detect clinically meaningful depression across diverse primary care populations, and familiar enough to PCPs that it has become the de facto standard for depression screening in the United States. The United States Preventive Services Task Force recommends screening for depression in the general adult population, and the PHQ-9 is among the instruments it endorses for that purpose .

One clarification is worth making explicitly before going further: the PHQ-9 is a screening instrument, not a diagnostic one. A score above the threshold does not constitute a diagnosis of major depressive disorder any more than an elevated hemoglobin A1c constitutes a diagnosis of diabetes—it is a signal that warrants clinical attention, not a verdict that replaces it. The analogy to the HbA1c is instructive precisely because that comparison is so often made uncritically in primary care settings, where labs carry a kind of authority that can tempt clinicians to treat the number as the conclusion. Depression is diagnosed through a clinical encounter: a history, a mental status examination, and the careful exclusion of other contributing factors. The PHQ-9 initiates that process; it does not complete it. Clinics that treat an elevated score as equivalent to a diagnosis—routing patients directly into treatment without a qualifying clinical assessment—are compressing a step that exists for good reasons.

In a functioning PCBH program, the PHQ-9 is not just a screening tool—it is a population health instrument. When administered routinely, it generates the referral stream. A score of 10 or above, which corresponds approximately to the threshold for moderate depression, typically triggers a warm handoff in well-designed programs. The specific threshold a clinic uses can and should be adjusted based on local capacity and patient population; the important point is that the threshold is explicit and consistent rather than left to the provider’s discretion in the moment. (GATHER: Routine; 4 Cs: First Contact—universal screening embeds behavioral health assessment as a standard part of every visit, not a response to flagged presentations.)

That consistency matters because provider discretion, in the absence of a structured protocol, tends to introduce exactly the kinds of biases that screening is designed to prevent. Pilipenko and Vivar-Ramon found that in a primary care clinic where depression screening was nominally routine, providers nonetheless administered it selectively—based on their own perception of whether screening was clinically relevant for a given patient. The screening was frequently not implemented as recommended, and providers often assisted patients in completing it, practices that compromise both the standardization and the validity of the instrument. A systematic pathway, in which the medical assistant administers the PHQ-9 as part of rooming every patient, removes that variability.

There is, however, a particular implementation failure worth naming here because it is more common than it should be. When a clinic leans heavily into universal screening without also thinking carefully about what happens next, elevated scores can generate a kind of automated triage that looks efficient but functions poorly. I have seen programs and clinics in which every PHQ-9 score above the threshold produces an Epic In Basket message routed to the BHC: “Patient with elevated PHQ-9, please call.” This approach sidelines the front desk staff and medical assistants—team members who often have the most consistent relationship with patients across visits and who are frequently well-positioned to facilitate a warm handoff, schedule a visit, offer a brief word of acknowledgment, or simply ensure the patient does not leave the building before the BHC has had a chance to say hello. It also implies, without quite saying so, that an elevated PHQ-9 is a problem only the BHC can address. That implication runs counter to everything the PCBH model stands for. A phone call from the BHC to a patient who has already gone home is sometimes exactly the right clinical move—there are moments when it is the most useful thing a BHC can do for a patient or a PCP—but it should be a deliberate clinical choice, not the default output of a poorly designed workflow. Screening protocols are only as good as the team-based response they trigger. (GATHER: Team-based; 4 Cs: Coordination—a screening protocol without a team-level response pathway functions as a detection system, not a care system.)

The PHQ-9 also serves a second function that is easy to overlook in discussions of initial assessment: it provides a baseline for tracking treatment response over time. Coley and colleagues examined how different metrics of treatment success behave across a large sample of patients with depression receiving psychotherapy in integrated health systems, and their analysis makes clear how much the choice of outcome metric matters for understanding whether a patient is improving. Using the PHQ-9 serially—at each visit, or at minimum at key intervals—makes that tracking possible and gives both the BHC and the PCP a shared language for discussing whether the patient is getting better.

That said, the PHQ-9 is not without its critics, and the honest clinician should know where the instrument’s limits lie. Concerns about its factorial validity have been raised for some time, and a recent clinimetric analysis by Cosci and colleagues concluded that the PHQ-9’s psychometric properties are “merely acceptable” and that substantial revision of its item wording would be needed to meaningfully improve construct validity. The cultural and linguistic performance of the instrument is a related concern. Martinez and colleagues conducted a systematic review and meta-analysis of Spanish-language versions of the PHQ-2 and PHQ-9, finding that while pooled sensitivity and specificity were acceptable, optimal cut-point scores varied considerably across studies—ranging from a score of 5 to 12 for the PHQ-9—raising real questions about whether the standard threshold of 10 translates reliably for Spanish-speaking patients. This matters especially in the primary care settings where PCBH is most commonly deployed, which are frequently safety-net clinics serving linguistically and culturally diverse populations.

There is also a meaningful tension between the population-level logic of measurement-based care and the individual clinical encounter. At the population level, tracking PHQ-9 scores across a panel allows a program to ask whether its patients are improving in aggregate—a genuinely important question. At the individual level, the picture is more complicated. Hlynsson and colleagues found that temporal measurement invariance in the PHQ-9 could not be convincingly established, meaning that changes in scores over the course of treatment may partly reflect shifts in how patients engage with the scale rather than genuine changes in depressive symptomatology. A patient’s PHQ-9 score on a given day is, in other words, a snapshot shaped by sleep, recent events, the clinical context, and how the questions were read—not a precise readout of depressive severity. Experienced BHCs learn to hold both frames simultaneously: the score is informative but not definitive, a starting point for a conversation rather than a verdict.

One item on the PHQ-9 warrants particular attention. Item 9 asks patients about thoughts of being better off dead or of hurting themselves. Simon and colleagues found, in an analysis of more than 84,000 outpatients, that endorsement of item 9 predicted subsequent suicide attempt and suicide death in a dose-response fashion: the more frequently patients reported suicidal ideation, the higher the cumulative risk over the following year. That finding underscores the item’s clinical significance, but it should not be read as a substitute for a proper assessment. Shaff and colleagues found that item 9 may be inadequate for identifying suicidal risk in multiracial and multiethnic adults, particularly older patients—a reminder that a single self-report item captures neither the complexity of suicidal ideation nor the range of its presentations across populations. A positive response to item 9 does not constitute a suicide assessment, but it does require one—which brings us briefly to the next topic.

A Note on Suicide and Safety

Any clinical encounter in which a patient screens positive for depression requires at minimum a brief inquiry into suicidal ideation. This is not optional, and it is not a task to be deferred. The BHC who receives a warm handoff for a PHQ-9 score of 12 and does not ask about item 9 has not completed the assessment.

Equally important: when item 9 is elevated, the responsibility for addressing it does not belong to the medical assistant who flagged the score, nor does it transfer cleanly to the BHC the moment the warm handoff begins or an In Basket message is sent. Suicidal risk must be evaluated and managed by a licensed clinician on the care team, before the patient leaves the clinic. In a well-functioning PCBH clinic, that typically means the BHC conducts the initial risk assessment and the PCP remains available—not waiting in the hallway, but genuinely reachable—for consultation if the clinical picture warrants a higher level of care or an immediate medical decision. Conversely, if the BHC is unavailable for any reason, the PCP retains the responsibility to conduct an appropriate suicide risk assessment and intervention. The warm handoff creates the conditions for collaboration; it does not dissolve the PCP’s responsibility for the patient in the building.

A full treatment of suicide risk assessment and safety planning in primary care is beyond the scope of this post, and it deserves one of its own. The warm handoff model is well-suited to this work: the same-day, face-to-face nature of the encounter gives the BHC an immediate window with a patient who is still in the building, and when item 9 is elevated, that handoff becomes more urgent, not less. A future post will address suicide and safety planning in primary care in the detail they require.

What the Warm Handoff Looks Like for Depression

The PCP closes the laptop, looks at the patient, and says something along these lines: “Your score on the depression screen today is higher than I’d like to see—this is something we check with everyone. I have a colleague right down the hall who I work closely with. She’s a behavioral health consultant, not a therapist, but someone who can help us figure out what’s going on and what to do about it. I’d like to introduce you to her before you leave today. It would just be a few minutes. Is that okay?”

The phrasing matters. The PCP is not transferring the patient to a mental health provider, which would trigger all the stigma that has historically kept patients from following through on mental health referrals. The PCP is bringing in a colleague—someone who works in this clinic, on this team, today. The research generally supports this mechanism: Horevitz and colleagues found that the in-person, same-day nature of the warm handoff was among the key factors patients cited in deciding to engage with behavioral health care. As Part One of this series noted, however, the same study found counterintuitive results among English-speaking Latino patients, a reminder that how the offer is framed and by whom can matter as much as the mechanism itself. Connection precedes commitment, and an introduction is a connection—but the quality of that introduction is not incidental.

When the BHC enters the room—or when the PCP walks the patient down the hall—the opening is brief. The BHC introduces herself (see this post about introducing yourself to a patient), acknowledges what the PCP has already shared, and begins a contextual interview before arriving at the functional question: “Tell me a little about what’s been going on and how it’s been affecting your day-to-day life.” The goal of the first 15–20 minutes is not a comprehensive psychiatric history. It is a contextual assessment: what is depression costing this patient in concrete, daily terms, and how can we change their context to facilitate change? A future post will address the Contextual Interview and why it is well-suited to initial primary care behavioral health visits.

For depression specifically, the structure of that initial encounter has a characteristic shape. Following the FACT visit flow described by Robinson and Reiter , the BHC begins not with symptoms but with life: what has the patient’s world looked like lately, and where has depression most visibly narrowed it? This Life Context assessment—brisk, curious, closer to a conversation than an intake—grounds the clinical picture in the patient’s actual daily functioning rather than a checklist of DSM criteria. From there, the BHC moves into Problem Context: what has the depression cost this person, what has worked before, and what has stopped working? The encounter closes not with a treatment plan in the traditional sense, but with a “behavioral experiment”—one specific, modest action the patient will take before the next contact, chosen because it reconnects them to something that mattered before depression contracted their world. Scheduling a walk. Calling a friend. Returning to a routine meal. This is behavioral activation in its most elemental form: not a protocol, but clinical logic, a contextually grounded intervention that makes sense for this person. The patient leaves with something to do, not a referral to follow up on. (GATHER: Generalist; GATHER: Highly productive—a brief, contextually grounded encounter addresses the presenting concern and leaves the patient with a concrete next step, without requiring specialty framing or extended session time.)

That plan travels in two directions before the patient leaves. A written after-visit summary goes home with the patient—delivered electronically through MyChart in settings that support it, or in lower-tech environments as something closer to a prescription pad: the plan written out by hand, legible, theirs to keep and refer back to. The same summary goes into the chart as part of the clinical note, which is one of many reasons an APSO format serves the PCBH context so well—placing the assessment and plan at the top where the PCP can see it immediately, without scrolling past a wall of subjective history to find out what was decided. The BHC and PCP can then connect face-to-face for a brief verbal handback while the patient is still in the building, or the note itself completes the communication loop. (GATHER: Team-based; 4 Cs: Coordination—structured documentation and a same-day verbal handback close the loop between BHC and PCP, keeping the care team aligned on the patient’s plan before they leave the building.)

The Drift to Watch For

Here is the implementation failure that deserves naming directly.

In a clinic that has just introduced PCBH, the PCPs have spent years managing depression largely on their own. The BHC arrives, the warm handoffs begin, and the feedback from patients is positive. The PCPs notice. They start making warm handoffs for every depressed patient they see. Within six months, the BHC’s schedule is a mood disorder caseload in all but name, and the patients with uncontrolled diabetes, chronic low back pain, and treatment-resistant hypertension—patients whose behavioral health needs are equally urgent and whose outcomes are measurably affected by behavioral intervention—are not getting to the BHC at all.

This is not a failure of clinical judgment on anyone’s part. It is a predictable consequence of doing exactly what felt natural and helpful, without building the structures that prevent a good instinct from becoming a limiting pattern. Williams frames this as a fundamental limitation of selective referral models: when access to behavioral health is determined by who presents with an obvious mental health concern, the patients who present with medical concerns and behavioral drivers never enter the stream.

The corrective is structural rather than exhortational. Pathways that build warm handoffs for chronic disease management into the clinic’s standard of care—a standing protocol, for example, that every patient newly diagnosed with type 2 diabetes receives a warm handoff—create the referral stream that keeps the BHC integrated across the full population the clinic serves. Those pathways will be the subject of future posts. For now, it is enough to name the drift, because a problem you can see is one you can prevent. (GATHER: Highly productive; 4 Cs: Comprehensiveness—population-level pathways extend behavioral health reach across the full range of conditions the clinic manages, not only those with an obvious mental health presentation.)

Conclusion

Depression is the right place to begin this clinical application series not because it is the BHC’s primary responsibility, but because it is the primary care patient’s most common behavioral health presentation and the one most likely to define the BHC’s early caseload in a new program. Understanding how the PHQ-9 generates the referral, how the warm handoff converts a positive screen into a clinical relationship, and how the BHC and PCP share the work of ongoing care gives the reader a template that carries, with adaptation, across the posts that follow. It also gives us a useful reference point for what can go wrong—the In Basket workflow, the mood disorder caseload, the diagnostic shortcut. Depression care in primary care should be a starting point, not a ceiling.

This post is an introduction, not an exhaustive treatment. Future posts will go deeper on what this one could only gesture at: suicide risk assessment and safety planning in the primary care setting; behavioral activation as a brief intervention for depression; and the tensions in measurement-based care between population-level tracking and individual clinical judgment. Each of those topics deserves its own careful attention.

References